Athanase Innovation AB Capital Reinvestment Ratio

Latest as of June 2024: 0.99x

Athanase Innovation AB capital reinvestment ratio. Athanase Innovation AB (ATIN) has a Capital Reinvestment Ratio of 0.99x as of June 2024, meaning it reinvests 1% of its operating cash flow (Skr6.54 Million) in capital expenditures (Skr6.49 Million). Check ATIN capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.99x
Capex / Operating Cash Flow

Operating Cash Flow

Skr6.54 Million
SEK

Capital Expenditures

Skr6.49 Million
SEK

Data as of

Jun 2024
Most recent filing

Capital Reinvestment Ratio of Athanase Innovation AB (2021–2021)

Capital reinvestment ratio of Athanase Innovation AB from 2021 to 2021. This chart tracks Athanase Innovation AB's Capital Reinvestment Ratio across 1 annual periods. Also explore Athanase Innovation AB net asset momentum to track the company's year-over-year net asset growth rate.

Athanase Innovation AB Capital Reinvestment Ratio by Year (2021–2021)

Athanase Innovation AB capital reinvestment ratio by year from 2021 to 2021. For the full cash flow conversion analysis, see Athanase Innovation AB (ATIN) cash flow conversion.

Year Reinvestment Ratio Operating CF (SEK) Capital Expenditures YoY Change
2021 0.00x Skr23.10 Million Skr65.00K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow